CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 7
The Gerszten/Welch Article Reviewed 

Current Surgical Management of Metastatic Spinal Disease

By Thomas E. Whitesides, Jr, MD, Emory University School of Medicine, Decatur, Georgia | July 1, 2000

The article by Drs. Gerszten and Welch is a broad, general, and philosophic review of the surgical options that are currently available for the care of our unfortunate patients with metastatic spinal disease. The authors document the poor outcomes of surgery in this setting until recent advances, which have led to improvements in care over the use of radiation therapy alone.

Shortcomings of Laminectomy

“Decompressive laminectomy” was once inappropriately considered the standard of care for this incurable condition. For many years, this procedure was performed because it was the only operation the average surgical practitioner knew how to perform.

In fact, laminectomy was not decompressive, because most metastases to the spine initially occur in the vertebral body, thereby causing bony destruction and/or neural element compression from the anterior. Laminectomy actually increased instability and pain by removing the remaining intact spinal elements, thus rendering the spine unstable and often worsening neurologic and ambulatory status.[1] Kyphosis developed, as in trauma, due to tumor destruction anteriorly and iatrogenic loss of spinal integrity posteriorly. Ultimately, laminectomy failed as it was not based on sound biomechanical principles.[2]

Foremost Goal: Improving Quality of Life

The primary goal of any therapy for patients with metastatic spinal disease cannot be cure. Treatment must be aimed at improving the quality of remaining life by relieving pain, and, if possible, avoiding neural deficit and allowing useful mobility. Fortunately, the evolution of biomechanical principles learned in the treatment of fractures [3] has spurred the development of more efficient surgical procedures, as well as US Food and Drug Administration (FDA) approval of much-improved metallic instrumentation. This progress, combined with therapeutic advances in drug and radiation therapy, has improved the quality of remaining life for many patients.

In the erect posture, the center of gravity is anterior to the spine. Thus, in this position, the vertebral bodies and discs contribute to spinal stability by their ability to resist compression. The posterior elements and ligaments must resist distraction, while ligaments and facet articular anatomy resist rotational stresses. The object of surgery, then, is to remove any tumor that may compress neural elements, to correct deformity, and to create a stable construct by replacing needed structural elements that have been lost. This, in turn, will relieve pain and allow mobilization in an erect posture.

In summary, modern techniques and instrumentation—when applied using sound biomechanical principles—have substantially improved quality of life for most of the time remaining to patients with metastatic spinal disease.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Peter C. Gerszten, MD, MPH and William C. Welch, MD, FACS


1. Morgan TH, Warton GW, Austin GN: The results of laminectomy in patients with incomplete spinal cord injuries. Paraplegia 9(1):14-23, 1971.

2. Guttman L: Spinal deformity in traumatic paraplegics and tetraplegics following surgical procedures. Paraplegia 7(1):38-58, 1969.

3. Holdsworth F: Fractures, dislocations, and fracture-dislocations of the spine. JBJS 45:6-20, 1963.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy